Ying Ding
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ying Ding has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Bei Zhang
Division of Otolaryngology, Department of Surgery, Head and Neck Surgery, The University of Hong Kong–Shenzhen Hospital, Shenzhen 518000, PR China
1 shared publication - Dan Zeng
Division of Otolaryngology, Department of Surgery, Head and Neck Surgery, The University of Hong Kong–Shenzhen Hospital, Shenzhen 518000, PR China
1 shared publication - Ping Zhou
Division of Otolaryngology, Department of Surgery, Head and Neck Surgery, The University of Hong Kong–Shenzhen Hospital, Shenzhen 518000, PR China
1 shared publication - Pingan Wu
Division of Head and Neck Surgery, Department of Surgery, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, P.R. China
1 shared publication - Rongfei Su
Division of Otolaryngology, Department of Surgery, Head and Neck Surgery, The University of Hong Kong–Shenzhen Hospital, Shenzhen 518000, PR China
1 shared publication - Xiaoling Qiu
The University of Hong Kong-Shenzhen Hospital, Department of Hematology, Shenzhen City, China
1 shared publication
Latest Publications
- Open Access
- 28 February 2024
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 45 (5) , 475-481
Clinical observation of Otitis Media Secretory during Covid-19
Objective: This study aims to analyze the onset of otitis media secretory, the peak period of infection with the Omicron strain of SARS-CoV-2 virus, and the time of transmigration during a pandemic of the Omicron strain. Additionally, the study aims to investigate to study the presence of SARS-CoV-2 virus in the middle ear cavity of patients with otitis media secretory and the survival time through a new method for detecting SARS-CoV-2 virus antigen in middle ear effusion. Methods: Retrospective comparison of the incidence of otitis media secretory during infection with SARS-CoV-2 virus Omicron strain from December 15, 2022, to January 15, 2023, versus the noninfection period from December 15, 2021, to January 15, 2022. We used a questionnaire star application to investigate the demographic and epidemiological characteristics of the 40 patients with otitis media secretory who participated in this study were investigated. A novel coronavirus (2019-nCoV) antigen detection kit (colloidal gold method) was used to detect middle ear effusion in patients with otitis media secretory. The data were statistically analyzed using SPSS 29.0 software. The measurement data are expressed as x ± s, the count data are expressed as the number of cases (%), and the data were compared using the χ2 test. p < 0.05 indicated a statistically significant difference. Results: During the SARS-CoV-2 virus Omicron strain pandemic, the incidence of otitis media secretory increased by 15% compared with the noninfection period. The peak infection period for the SARS-CoV-2 virus Omicron strain was December 25, 2022, and December 15, 2022, and the peak time of conversion was 7 to 9 days after the infection. Middle ear effusion SARS-CoV-2 virus antigen testing was performed in patients with otitis media secretory after conversion; 5 patients (12%) were positive, and 35 patients (88%) were negative. The disease duration in patients with negative results was more than 3 weeks. Conclusions: Otitis media secretory is one of the most common ear complications after infection with the Omicron strain of SARS-CoV-2 virus, and the significantly higher incidence is associated with middle ear viral infection. Middle ear effusion SARS-CoV-2 virus antigen test detected the virus, which survived longer in the middle ear effusion than in the nasal cavity. The middle ear effusion test can detect SARS-CoV-2 virus antigen and determine whether the organism contains virus residue.
- 28 February 2024
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 45 (5) , 475-481
Open AccessClinical observation of Otitis Media Secretory during Covid-19
Objective: This study aims to analyze the onset of otitis media secretory, the peak period of infection with the Omicron strain of SARS-CoV-2 virus, and the time of transmigration during a pandemic of the Omicron strain. Additionally, the study aims to investigate to study the presence of SARS-CoV-2 virus in the middle ear cavity of patients with otitis media secretory and the survival time through a new method for detecting SARS-CoV-2 virus antigen in middle ear effusion. Methods: Retrospective comparison of the incidence of otitis media secretory during infection with SARS-CoV-2 virus Omicron strain from December 15, 2022, to January 15, 2023, versus the noninfection period from December 15, 2021, to January 15, 2022. We used a questionnaire star application to investigate the demographic and epidemiological characteristics of the 40 patients with otitis media secretory who participated in this study were investigated. A novel coronavirus (2019-nCoV) antigen detection kit (colloidal gold method) was used to detect middle ear effusion in patients with otitis media secretory. The data were statistically analyzed using SPSS 29.0 software. The measurement data are expressed as x ± s, the count data are expressed as the number of cases (%), and the data were compared using the χ2 test. p < 0.05 indicated a statistically significant difference. Results: During the SARS-CoV-2 virus Omicron strain pandemic, the incidence of otitis media secretory increased by 15% compared with the noninfection period. The peak infection period for the SARS-CoV-2 virus Omicron strain was December 25, 2022, and December 15, 2022, and the peak time of conversion was 7 to 9 days after the infection. Middle ear effusion SARS-CoV-2 virus antigen testing was performed in patients with otitis media secretory after conversion; 5 patients (12%) were positive, and 35 patients (88%) were negative. The disease duration in patients with negative results was more than 3 weeks. Conclusions: Otitis media secretory is one of the most common ear complications after infection with the Omicron strain of SARS-CoV-2 virus, and the significantly higher incidence is associated with middle ear viral infection. Middle ear effusion SARS-CoV-2 virus antigen test detected the virus, which survived longer in the middle ear effusion than in the nasal cavity. The middle ear effusion test can detect SARS-CoV-2 virus antigen and determine whether the organism contains virus residue.
- Open Access
- 28 June 2023
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 89 (4) , 101286
Amyloidosis of the tongue: a rare case report
- 28 June 2023
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 89 (4) , 101286
Open AccessAmyloidosis of the tongue: a rare case report